Osmotic Demyelination Syndrome Associated with Uremia and Elevated Serum Osmolality

Smithline N, Gardner KD Jr. Gaps–anionic and osmolal. JAMA. 1976;236(14):1594–7.

Dabrowski W, Siwicka-Gieroba D, Robba C, Bielacz M, Sołek-Pastuszka J, Kotfis K, et al. Potentially detrimental effects of hyperosmolality in patients treated for traumatic brain injury. J Clin Med. 2021;10(18):4141.

Barhaghi K, Molchanova-Cook O, Rosenburg M, Deal B, Palacios E, Nguyen J, et al. Osmotic demyelination syndrome revisited: review with neuroimaging. J La State Med Soc. 2017;169(4):89–93.

Lambeck J, Hieber M, Dreßing A, Niesen WD. Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int. 2019;116(35–6):600–6.

Han MJ, Kim DH, Kim YH, Yang IM, Park JH, Hong MK. A case of osmotic demyelination presenting with severe hypernatremia. Electrolyte Blood Press. 2015;13(1):30–6.

Ocak Ö, Urfalı FE, Korkmazer B, ÖzışıkKaraman HI. Osmotic demyelination syndrome in a normonatremic patient with chronic kidney disease. Meandros Med Dent J. 2020;21(1):89–92.

Beh SC. Temporal evolution of the trident and piglet signs of osmotic demyelination syndrome. J Neurol Sci. 2017;373:268–73.

Rao PB, Azim A, Singh N, Baronia AK, Kumar A, Poddar B. Osmotic demyelination syndrome in intensive care unit. Indian J Crit Care Med. 2015;19(3):166–9.

Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-42.

Beraldo DO, Duarte SBCP, Santos RB, Mendes CG, Silveira MP, Neto AS, et al. Pontine myelinolysis caused by hypovolemic hypernatremia. Case Rep Nephrol. 2020;2020:4079098.

MacMillan TE, Shin S, Topf J, Kwan JL, Weinerman A, Tang T, et al. Osmotic demyelination syndrome in patients hospitalized with hyponatremia. NEJM Evid. 2023;2(4):EVIDoa2200215.

Jahan M, Sharma S, Rehmani R. Osmotic demyelination syndrome despite appropriate hyponatremia correction. Cureus. 2020;12(5):e8209.

Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3):iii22–8.

Seethapathy H, Zhao S, Ouyang T, Passos C, Sarang A, Cheung PW, et al. Severe hyponatremia correction, mortality, and central pontine myelinolysis. NEJM Evid. 2023;2(10):EVIDoa2300107.

Tandukar S, Sterns RH, Rondon-Berrios H. Osmotic demyelination syndrome following correction of hyponatremia by ≤ 10 mEq/L per day. Kidney360. 2021;2(9):1415–23.

Kinoshita T, Mlodzinski E, Xiao Q, Sherak R, Raines NH, Celi LA. Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes. J Crit Care. 2023;77:154325.

Silver SM, Sterns RH, Halperin ML. Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis. 1996;28(1):1–13.

GankamKengne F, Nicaise C, Soupart A, Boom A, Schiettecatte J, Pochet R, et al. Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol. 2011;22(10):1834–45.

Bodonyi-Kovacs G, Lecker SH. Electrolyte-free water clearance: a key to the diagnosis of hypernatremia in resolving acute renal failure. Clin Exp Nephrol. 2008;12(1):74–8.